TEK and neoplasm: Targeting the Ang–Tie2 pathway with soluble Tie2 (sTie2) has been shown to block tumor angiogenesis [21], and nuclease-resistant RNA aptamer specific for Ang2 also inhibits rat corneal neovascularization [22].